MCA registered Company Details
InsightsCompaniesSectorsDirectorsInvestorsCompare
RegisterKaro › MCA registered Company Details

Symbiotec Pharmalab Limited

U24232MP2002PLC015293ActivePrivateUnlisted
Last updated: 2026-06-10
30
Compliance Health · F
3 / 9 signals passed

Symbiotec Pharmalab Limited is a Private Indian company incorporated in 2002 and based in Madhya Pradesh, India. Symbiotec Pharmalab Limited operates in Pharmaceuticals & Chemicals (NIC 24232) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.

Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7Health F · 30/100
Revenue (latest FY)
—
Awaiting extraction
PAT (latest FY)
—
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
—
—
Filings on Record
0
All current
Incorporated
2002
24 years old
State
Madhya Pradesh
Sector
Pharmaceuticals & Chemicals
NIC 24232
Class
Private
Sub-category
—
Authorized Capital
—
Paid-up Capital
—
Members
—
Last AGM
—
Last Balance Sheet
—
Latest Filing
—
Registered Email
—
Registered Office
—
SYMBIOTEC PHARMALAB LIMITEDTRACXN · PUBLIC DATA
Brand SYMBIOTEC PHARMALAB LIMITED · Legal entity Symbiotec Pharmalab Limited

SYMBIOTEC PHARMALAB LIMITED is the legal entity of Symbiotec and Symbiotec.

Total Funding
Latest Round
—
Revenue
Valuation
Funding Rounds
—
Employees
1,344
Stage
Public
HQ
—
Founded
2002
Source: Tracxn (public profile) · joined to MCA on CIN U24232MP2002PLC015293

Quick facts

Identity · Activity · Auditor · Contact
Registered office
—
NIC code
24232
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
—
Section
Pharmaceuticals & Chemicals
ROC
—
Website
https://smartodr.in/login
Class · sub-category
Private
Incorporation · Last AGM
— · —

Directors

From MGT-7 annual returnLocked
SG
Sneha Gupta
Additional Director
3.8y · Chennai · DIN 8361588
DR
Deepa Reddy
Director
2.9y · Pune · DIN 1830716
AM
Arun Malhotra
Whole-time Director
4.7y · Pune · DIN 8283342
Get the full board of directors

Directors, DINs & appointment history for Symbiotec Pharmalab Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

MCA Filings

AOC-4 · MGT-7 historyLocked
FormFYFiledDueDelayStatus
AOC-4FY2024-2530 Oct 202430 Oct 20240dfiled
MGT-7FY2024-2524 Nov 202429 Nov 20240dfiled
AOC-4FY2023-2430 Oct 202330 Oct 2023+9dfiled
MGT-7FY2023-2425 Nov 202329 Nov 20230dfiled
AOC-4FY2022-2330 Oct 202230 Oct 20220dfiled
MGT-7FY2022-2321 Nov 202229 Nov 20220dfiled
Get financial statements & other filing documents

Full MCA filing history for Symbiotec Pharmalab Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked
Charge IDHolderAmountCreatedStatus
347111415HDFC Bank Ltd(Bank)₹23.92 Cr04 Jul 2023Open
643535678Axis Bank Ltd(Bank)₹3.69 Cr27 Jan 2020Open
743155834ICICI Bank Ltd(Bank)₹18.76 Cr27 Jan 2020Open
826765866HDFC Bank Ltd(Bank)₹12.62 Cr27 Jan 2021Open
871895331HDFC Bank Ltd(Bank)₹8.71 Cr04 Jul 2021Open
See registered charges & lenders

Charge IDs, lenders & amounts for Symbiotec Pharmalab Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Financial Performance

Revenue · PAT · Net worth by FYLocked
FYRevenuePATNet WorthTotal AssetsEmployees
FY2024-25₹17.19 Cr₹1.71 Cr₹11.44 Cr₹21.64 Cr129
FY2023-24₹14.09 Cr₹1.16 Cr₹5.31 Cr₹14.83 Cr322
FY2022-23₹14.16 Cr₹1.29 Cr₹7.51 Cr₹14.55 Cr330
FY2021-22₹11.34 Cr₹1.23 Cr₹4.60 Cr₹11.08 Cr205
Gain deeper financial insights of this entity

Audited financials & ratios for Symbiotec Pharmalab Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Detailed Financials

Income statement + balance sheetLocked
Line itemFY2024-25FY2023-24FY2022-23FY2021-22
Income statement
Revenue from operations₹17.19 Cr₹14.09 Cr₹14.16 Cr₹11.34 Cr
Other income₹10.49 L₹49.86 L₹33.71 L₹42.27 L
Total income₹17.30 Cr₹14.59 Cr₹14.50 Cr₹11.76 Cr
Total expenses₹15.11 Cr₹13.10 Cr₹12.84 Cr₹10.19 Cr
Profit before tax₹2.22 Cr₹1.51 Cr₹1.68 Cr₹1.59 Cr
Profit / (Loss) after tax₹1.71 Cr₹1.16 Cr₹1.29 Cr₹1.23 Cr
Balance sheet
Equity / Net worth₹11.44 Cr₹5.31 Cr₹7.51 Cr₹4.60 Cr
Borrowings₹5.10 Cr₹4.04 Cr₹2.10 Cr₹2.71 Cr
Current liabilities₹4.38 Cr₹4.04 Cr₹3.22 Cr₹2.64 Cr
Total liabilities₹10.19 Cr₹9.51 Cr₹7.04 Cr₹6.48 Cr
Current assets₹8.79 Cr₹6.68 Cr₹6.98 Cr₹5.69 Cr
Cash & equivalents₹1.46 Cr₹1.32 Cr₹1.71 Cr₹1.73 Cr
Total assets₹21.64 Cr₹14.83 Cr₹14.55 Cr₹11.08 Cr
Employees129322330205
Gain deeper financial insights of this entity

Audited financials & ratios for Symbiotec Pharmalab Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Compounded Annual Growth Rate

Derived from multi-FY filingsLocked
MetricLatest value1Y CAGR3Y CAGR5Y CAGR
Revenue₹17.19 Cr+16.5%+2.1%+9.6%
Profit after Tax₹1.71 Cr+20.8%-5.1%+19.0%
Net Worth₹11.44 Cr+7.5%-5.2%-2.5%
Employees129-8.2%+24.0%+7.4%
Gain deeper financial insights of this entity

Audited financials & ratios for Symbiotec Pharmalab Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Financial Ratios

Profitability · leverage · efficiencyLocked
FYRevenuePATPAT marginRev growthROEROAD/ERev/emp
FY2024-25₹17.19 Cr₹1.71 Cr+9.95%+10.13%+14.95%+7.90%0.45₹13.33 L
FY2023-24₹14.09 Cr₹1.16 Cr+8.26%+4.83%+21.92%+7.85%0.76₹4.38 L
FY2022-23₹14.16 Cr₹1.29 Cr+9.14%+20.41%+17.23%+8.89%0.28₹4.29 L
FY2021-22₹11.34 Cr₹1.23 Cr+10.81%+23.26%+26.64%+11.06%0.59₹5.53 L
Gain deeper financial insights of this entity

Audited financials & ratios for Symbiotec Pharmalab Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Cap Table & Shareholding

Promoter · institutional · publicLocked
CategoryShareholdersShares held%
Promoters22,14,94,40581.74%
Institutional Investors322,46,6238.54%
Public & Others1325,54,7829.72%
See the full shareholding pattern

Promoter, institutional & public holding for Symbiotec Pharmalab Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Peer Benchmark

4 peersSame sector + state + ±5y vintage
MetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
—
PAT (latest FY)
—
Employees
—
—
—
—
Paid-up capital
—
Compliance Health
63
96
96
Bottom quartile · P0

Top 10 in Pharmaceuticals & Chemicals

by healthView all ›
01
Paid-up
Revenue
A · 96
02
Paid-up
Revenue
A · 96
03
Paid-up
Revenue
A · 96
04
Paid-up
Revenue
A · 96
05
S B Organics Ltd
Telangana · Inc 1988
Paid-up
Revenue
A · 96
06
Ecmas Resins PVT Ltd
Telangana · Inc 1987
Paid-up
Revenue
A · 96
07
Srinivasa Cystine Private Ltd
Telangana · Inc 1983
Paid-up
Revenue
A · 96
08
Paid-up
Revenue
A · 96
09
Paid-up
Revenue
A · 96
10
Paid-up
Revenue
A · 96

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned
GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned
MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned
AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned
CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned
IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned
IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned
eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Symbiotec Pharmalab Limited

When was Symbiotec Pharmalab Limited incorporated?
Symbiotec Pharmalab Limited was incorporated in 2002. Its CIN is U24232MP2002PLC015293 and it is registered with the relevant Registrar of Companies.
Where is Symbiotec Pharmalab Limited located?
Symbiotec Pharmalab Limited is headquartered in Madhya Pradesh.
What sector does Symbiotec Pharmalab Limited operate in?
Symbiotec Pharmalab Limited operates in the Pharmaceuticals & Chemicals sector (NIC code 24232), classified as Indian Non-Govt Company.
Who are the directors of Symbiotec Pharmalab Limited?
Director details for Symbiotec Pharmalab Limited have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Symbiotec Pharmalab Limited?
Symbiotec Pharmalab Limited has authorized capital of — and paid-up capital of —.
Does Symbiotec Pharmalab Limited have any open charges?
Symbiotec Pharmalab Limited has no open MCA-registered charges on record.
What is Symbiotec Pharmalab Limited's Compliance Health Score?
RegisterKaro's Compliance Health Score for Symbiotec Pharmalab Limited is 30/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 3 of 9 signals passed.